News

Search here results

• Cancer drugs could target autoimmune diseases | UCL Cancer Institute - UCL – University College London
• Cancer Research UK-UCL Centre receives £4m Accelerator Award | UCL Cancer Institute - UCL – University College London
• Dr Martin Pule named BBSRC Most Promising Innovator 2016 | UCL Cancer Institute - UCL – University College London
• Epigenetics discovery provides new insight into cellular memory | UCL Cancer Institute - UCL – University College London
• Gene editing activates cancer-killing immune cells | UCL Cancer Institute - UCL – University College London
• UCL UCLH Public Open Day 2016 | UCL Cancer Institute - UCL – University College London
• Cancer drug could treat blood vessel deformities | UCL Cancer Institute - UCL – University College London
• ICON6 trial finds cediranib improves outcomes for women with recurrent ovarian cancer | UCL Cancer Institute - UCL – University College London
• New genetics discovery paves the way to transform immunotherapy treatments | UCL Cancer Institute - UCL – University College London
• Dr Derralynn Hughes honoured by NHS National Institute for Health Research (NIHS) award | UCL Cancer Institute - UCL – University College London